Background and Objectives: The neurofilament light chain (NfL) is a biomarker for neuro-axonal injury in various acute and chronic neurological disorders, including Alzheimer’s disease (AD). The gene discussed is NEFL; the disease is early-onset autosomal dominant Alzheimer disease.